HEMP flower for sale in Switzerland
HEMP flower for sale in Switzerland
A Swiss government advisory commission has called for cannabis to be decriminalised and for
the market to be regulated in the Alpine country.
The Federal Commission for Addiction Issues said on Tuesdayexternal link that cannabis use in
Switzerland had not changed significantly in the past ten years. Despite its popularity, the
percentage of problematic users is low, it said.
The risks of cannabis are mainly linked to high amounts of THC [active ingredient], early
use among teenagers, prolonged use, mixing cannabis and tobacco, and if it is used by people
with existing mental problems.
The commission recommends Switzerland legalise and regulate the market while protecting the
health of its population, especially young people.
It added that there should be certain controls over the market. This would also help scientific
research and access to cannabinoids for medical purposes.
+ In-depth look at the renaissance of cannabis in Switzerlandexternal link
Growing, consuming and dealing cannabis are all forbidden in Switzerland. But anyone over 18
caught in possession of up to ten grams of cannabis will receive a CHF100 ($110) fine and not
have it put on their criminal record.
Some 200,000 people in Switzerland use illegal cannabis, the government estimates, despite its
Consumption is much more prevalent among men, teenagers and young adults. Most are
occasional users, with around 1% of the adult population admitting frequent use, over more
than 20 days per month.
The government is meanwhile is proposing limited pilot projects allowing up to 5,000 people to
smoke marijuana legally, which may lead to changes in laws banning cannabis that date back to
1951. The plan has been put out for public comment until mid-year.
The government also plans to make it easier for people to access medical marijuanexternal
linka, but that would be part of a separate process.
Switzerland already allows cannabis products of less than 1% THC. It began last July to explore
new ways of regulating more potent marijuana, after the University of Bern was blocked by
existing law from undertaking a scientific study.
Several US states have relaxed restrictions on marijuana, seeing an opportunity to save money
on law enforcement and profit from taxing the drug. In Europe, Portugal and the Czech Republic
have decriminalised cannabis and Luxembourg is discussing legalisation.
Switzerland has developed its own brand of cannabis reform over the last several years. Low
THC cannabis is now sold in shops. Cannabis is now used by about 200,000 people.
The country has now proposed pilot programs to make it easier for people with chronic
conditions like MS or cancer to access the drug and, much like Germany, obtain insurance
reimbursement for the same. Only about 3,000 patients currently have the medical exemption
necessary to obtain higher THC versions of the plant or drugs. This process is painful, time-
consuming, and arduous for patients, as well as their caretakers.
By the summer of 2019, however, the Swiss Interior Ministry will publish a proposal to
streamline the process and the Health Ministry will examine how to resolve insurance
Despite the flourishing of the CBD industry, current laws still forbid consumption of higher THC
cannabis and seek to punish it. That said, the number of actual prosecutions is declining while
consumption is not. This means that the underground market is flourishing, and the safety of
consumers is still very much at risk.
The Swiss government, like many others around the world, is essentially throwing in the towel
and bowing to reality.
Several Swiss cities and cantons (Swiss states) are now seeking to undertake studies to
examine different models for regulation, with proposed changes in federal law to allow such
studies to take place.
Why Is Switzerland Such An Interesting Cannabis Market?
The first reason that Switzerland is such an interesting market is that while it sits in the center of
Europe, it is not part of the EU. This means that once the Swiss cannabis market gets going
(see the CBD market), it will not be subject to the pace of reform mandated by EU member
states. The sale of low potency cannabis has been legal in Switzerland since 2011 and has
escalated over the last two years.
Switzerland has already benefited economically from limited cannabis sales, such as medical,
CBD, and low potency products. Tax revenue from completely legalizing the market will
obviously be a major boon to the government’s coffers that has certainly driven the discussion
forward among policymakers. Swiss production is already up with Swiss companies, including
pharmaceutical and wellness companies beginning to define the domestic market, but multiple
companies in the established global industry are also establishing a presence in the country.
So while it is still uncertain when full-bore cannabis reform will actually come, it is clearly in the
cards. Just like other countries in Europe and around the world now, the green revolution is
gaining speed and will not be stopped.
A proposal was drafted in 2013, which succeeded in gaining enough public support. As a result,
the Slovenian government re-classified cannabinoids as Class II illegal drugs – from the original
Class I – thus allowing for the medical use of cannabinoid drugs but not cannabis flowers.
This is an important distinction. The new classification changed its description from a substance
deemed “very dangerous” to human health to one that can be acceptable for “medical usage”.
In December of 2016, the Ministry of Health produced a draft of legislation that would allow a
regulated medical cannabis program. The initial draft would allow patients access to doctor
prescribed flowers, extracts and synthetic variations but cultivation would remain illegal.
Cannabis cannot be cultivated, produced, or possessed – a rather strange stipulation for a law
intended to make cannabis more accessible to patients.
(Paul Hornby and Dean Herenda at Cannabis Renaissance 2017, Demistifying Cannabis)
Dean Herenda, Secretary for the Ministry of Infrastructure and one of the most prominent
advocates of cannabis legalisation in Slovenia, explained in March 2017 that the new laws were
damaging to both the cannabis market and the agricultural industry-
“In agriculture, the growth of hemp and its products (high CBD extracts, seeds, hemp oil, teas)
are de facto prohibited, because the plant (no matter the amount of THC) is fully transferred to
the second category of substances, which is overseen by the Ministry of Health. We believe that
the impact of this regulation represents a serious blow to agriculture and the economy.
Legal CBD hemp In Switzerland Last update: 18.06.2018 Information and legal situation in
Switzerland The hemp plant contains over 80 cannabinoids and over 400 other active
substances. The most important cannabinoids are the intoxicating Tetrahydrocannabinol (THC)
and the nonintoxicating Cannabidiol (CBD), which also reduces the psychotropic effect of THC.
Unlike THC (Tetrahydrocannabinol), Cannabidiol (CBD) is not subject to the Narcotics Act
because it has no comparable psychoactive effect. In order for products containing CBD to be
legally marketed, it must comply with the legislation according to which it is placed on the
market: according to the allocation, the corresponding Swiss legislation applies (see info
Document of the Federal Office of Health and Swissmedic). Legal Requirements Tobacco
replacement products The following requirements apply to products which are to be placed on
the market as tobacco substitutes: 1. According to the Tobacco Regulation (article 3), tobacco
substitute products must comply with the requirements of the tobacco products they replace.
For example, herbal cigarettes such as tobacco cigarettes would also have to bear picture
warnings. 2. In normal use, the replacement products may not endanger the health directly or in
an unexpected manner. This requires that they are not acutely toxic and do not have any
content or foreign substances that the consumer does not expect. 3. The third requirement is
that tobacco substitute products should not have any psychotropic effects in order to exclude
the use of tobacco substitutes such as narcotics for smokers. As regards the plants used as
substitutes for tobacco, for example for herbal mixtures for smoking, no limit values are set for
THC or CBD. Such substances for THC exist for narcotics and foodstuffs (see Foreign and
Ingredient Ordinance [FIV, SR 817.021.23]). Concerning the stun effect, this must be interpreted
in such a way as to replace-Products may not contain raw materials or products listed in the lists
a to E of the Narcotics Directory Ordinance (SR 812.121.11). This regulation introduces
cannabis products from a total THC content of 1% as banned controlled substances (directory
D). Hemp with a total THC content of below 1% is therefore considered to be nonpsychotropic
and can also be sold as a substitute for tobacco products. Cannabidiol (CBD) is not a narcotic
drug in accordance with narcotics law.